Recombinant human lactoferrin to treat oral mucositis

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DE015914-01
Agency Tracking Number: DE015914
Amount: $349,929.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
AGENNIX, INC.
AGENNIX, INC., 8 GREENWAY PLZ, STE 910, HOUSTON, TX, 77046
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ATUL Varadhachary
 (713) 552-1091
 AVARADHACHARY@AGENNIX.COM
Business Contact
 RICK BARSKY
Phone: (713) 552-1091
Email: RBARSKY@AGENNIX.COM
Research Institution
N/A
Abstract
DESCRIPTION: Oral mucositis is a major dose-limiting toxic effect of intensive cancer chemotherapy and radiotherapy. In addition to the morbidity directly caused by severe oral mucositis, it can cause secondary morbidities by limiting oral intake or e

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government